Canada - Re-Export of Heterocyclic Compounds with Unfused Imidazole Ring

Since 2014, Canada Re-Export of Heterocyclic Compounds with Unfused Imidazole Ring jumped by 42.6% year on year. In 2019, the country was number 4 comparing other countries in Re-Export of Heterocyclic Compounds with Unfused Imidazole Ring at $718,034.44. Canada is overtaken by United Arab Emirates, which was number 3 at $1,405,592.5 and is followed by Jordan at $48,298.6. United States ranked the highest with $150,565,061.97 in 2019, that is a growth of 46.4% compared to 2018. United States witnessed the best average annual growth at +89% per year, while Jordan recorded the worst performance at -19.6% per year.

Loading...

Date US Dollars
2019 718,034.44
2018 341,213.03
2017 207,081.11
2016 205,141.77
2015 49,197.00
Download all data from 2000 to 2019

How does Canada rank in Re-Export of Heterocyclic Compounds with Unfused Imidazole Ring?

# 6 Countries US Dollars Last YoY 5‑years CAGR
1 #1
United States
150,565,061.97 2019 +46.4 % +89.0 % View data
2 #2
Cyprus
3,511,010.51 2019 -11.0 % -2.8 % View data
3 #3
United Arab Emirates
1,405,592.50 2018 -61.8 % +12.5 % View data
4 #4
Canada
718,034.44 2019 +110.4 % +42.6 % View data
5 #5
Jordan
48,298.60 2018 +53.9 % -19.6 % View data
Compare all 6 countries

Go Top